Illumination Acquisition Corp I (ILLUU) 股票分析
金融服务Illumination Acquisition Corp I
$9.96
$-0.04 (-0.40%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Illumination Acquisition Corp I is a special purpose acquisition company (SPAC) dedicated to effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses within the nuclear, artificial intelligence/high performance computing, technology, or industrial growth sectors. The company operates within the Financial Services sector and is specifically classified under the industry of Shell Companies, which denotes its current status as a publicly traded vehicle awaiting a target business combination rather than an operating entity with its own standalone revenue streams. Regarding its scale, the market capitalization, annual revenue, and employee count are currently not available in the provided data, reflecting the structural nature of the company as a blank-check entity prior to a merger transaction. The absence of specific market cap and revenue figures indicates that the company's valuation is currently derived primarily from its trust account assets rather than operational earnings, while the lack of an employee count confirms that the corporate infrastructure is minimal, focused entirely on the administrative and legal processes required to complete a future business combination.
财务健康
The reported revenue for the trailing twelve months, net income, and EBITDA are all listed as not available, which is consistent with the financial reporting standards for a shell company that has not yet identified a target or generated operating income; consequently, the gap between revenue and net income cannot be analyzed as there is no operating revenue to offset against costs. Similarly, free cash flow, total cash, and total debt figures are not available, meaning the company's financial flexibility is currently defined by the funds held in its trust account rather than cash generated from operations or debt repayment capacity. The gross margin, operating margin, and profit margin are all recorded at 0.0%, a figure that accurately reflects the company's status as a non-operating shell with no sales to generate gross profit or operating income before expenses. While specific cash and debt numbers are unavailable, the 0.0% profit margins imply that the company is not generating profit from operations, relying instead on equity financing for its existence. The current ratio, return on equity, return on assets, and debt-to-equity ratio are all marked as not available, preventing a direct quantitative assessment of short-term liquidity or management effectiveness in generating returns on tangible assets. These missing metrics, combined with the 0.0% margins, suggest that traditional financial health indicators used for mature operating companies are not applicable to this entity at this stage, as its primary financial characteristic is the preservation of trust assets pending a merger.
估值评估
The trailing P/E ratio and forward P/E ratio are not available, indicating that the company has not yet reported earnings per share that would allow for a traditional price-to-earnings valuation, and thus no difference between them can be calculated to imply an expected earnings trajectory. The price-to-book ratio is not available, which means the market premium over book value cannot be determined without specific book equity data relative to the current share price. The price-to-sales ratio and EV/EBITDA are also not available, suggesting that alternative valuation metrics typically used for growth companies or those with negative earnings are currently inapplicable or undefined for this shell company. Regarding the trading range, the 52-week high is recorded at $9.99 and the 52-week low at $9.90; however, the current price position relative to this range cannot be precisely calculated without the real-time share price, though the narrow spread between the high and low indicates limited price volatility within this specific period. The beta value is not available, so it is impossible to quantify the stock's price volatility relative to the broader market based on the provided facts. The combination of unavailable P/E, P/S, and EV/EBITDA metrics alongside the narrow 52-week trading range highlights that the stock's valuation is currently driven by SPAC-specific dynamics and trust account levels rather than standard fundamental multiples.
Growth & Income
The revenue growth and earnings growth rates for the year-over-year period are not available, as the company has not yet engaged in business operations that would generate comparable historical data for growth calculations. Since the company is not a dividend payer, there is no dividend yield or payout ratio to state, and the company does not distribute earnings to shareholders but rather retains capital within the trust for the purpose of a future merger. Consequently, the company reinvests its available capital, derived from the initial public offering and any subsequent offerings, into the pursuit of a target business in the nuclear, artificial intelligence, technology, or industrial sectors rather than paying out income to investors. The overall growth and income profile is characterized by the absence of historical growth data and dividend payments, with the company's value proposition entirely dependent on the successful identification and consummation of a business combination that will subsequently generate revenue and earnings growth.
同行比较
Illumination Acquisition Corp I (ILLUU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Illumination Acquisition Corp I | ILLUU | N/A | N/A |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。Illumination Acquisition Corp I的市盈率为N/A。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于Illumination Acquisition Corp I
Illumination Acquisition Corp I focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the nuclear, artificial intelligence/high performance computing, technology, industrial growth, and financial services industries. The company was incorporated in 2025 and is based in New York, New York.
公司简介以英文显示。